Andy Birchfield in the News

Photo of Andy Birchfield Andy D. Birchfield , Jr.
Lead Attorney in $4.85 Billion Vioxx Settlement
 

Articles 31 to 40 of 100 for attorney Andy Birchfield .

Merck's Fight Looks Tougher in NJ

| February 27, 2006
Merck's got three victories and only one loss under its belt in the ongoing Vioxx litigation battle, but the upcoming cases could get a lot tougher.

Update 8: Jury Begins Deliberating in Vioxx Retrial

| February 17, 2006
A federal jury began considering a plaintiff's claim that Merck & Co. ignored evidence that its blockbuster drug Vioxx caused heart attacks and that the medicine probably caused the death of a 53-year old Florida man.

Merck Rests Defense in Vioxx Retrial

| February 16, 2006
Merck & Co. rested its defense Thursday in the first federal Vioxx case. Attorneys will give closing arguments Friday morning, U.S. District Judge Eldon Fallon told jurors.

Scientist Cross-Examined in Vioxx Retrial

| February 16, 2006
Using a big black, red and yellow chart labeled "Merck Knew But No Warning" to emphasize his points, a plaintiff's attorney cross-examined a top scientific executive for the drug company.

Attorney: Vioxx to Blame for Mans Death

| February 6, 2006
An attorney for a woman whose husband died of a heart attack after taking Vioxx for a month told a jury Monday he will prove that the drug was to blame and that its maker hid the dangers.

Key Figures in First Federal Vioxx Trial

| December 12, 2005
Here's a look at key players in the nation's third Vioxx-related civil trial, and the first to go before a federal jury. The judge in the case declared a mistrial because of a hung jury after about 18 hours of deliberations over three days.

Jury to Resume Deliberations in Vioxx Case

| December 9, 2005
Jurors in the first federal trial over Vioxx were to resume deliberating about whether Merck & Co. was negligent in designing and marketing the once-popular painkiller and if it failed to warn about the drug's risks.

Jury Resumes Work in Vioxx Trial

The Associated Press | December 9, 2005
HOUSTON - Jurors in the first federal trial over Vioxx were to resume deliberating about whether Merck & Co. was negligent in designing and marketing the once-popular painkiller and if it failed to warn about the drug's risks.

Jurors in Vioxx trial Deliberate two hours without Verdict

The Associated Press | December 8, 2005
Jurors deliberated about two hours Thursday without reaching a verdict in the first trial stemming from a federal lawsuit against Merck & Co. over its once-popular painkiller Vioxx.

Merck Accused of Putting Vioxx Profits Before Safety

Bloomberg | December 8, 2005
Dec. 8 (Bloomberg) -- Merck & Co. put profits ahead of consumers' safety by hiding heart risks of its Vioxx painkiller, a lawyer told a jury in closing arguments of the third trial of a lawsuit filed over the drug.